NARA — Pangenomic Health Balance Sheet
0.000.00%
Last trade - 00:00
- CA$3.20m
- CA$3.81m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.002 | 0.038 | 1.35 | 0.089 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.003 | 0.108 | 0.041 | 0.192 |
Prepaid Expenses | ||||
Total Current Assets | 0.006 | 0.147 | 1.67 | 0.484 |
Net Property, Plant And Equipment | — | 0 | 0.025 | 0.02 |
Net Intangible Assets | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 0.006 | 0.147 | 2.58 | 0.504 |
Payable / Accrued | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.003 | 0.136 | 0.334 | 0.719 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 0.003 | 0.136 | 0.334 | 0.719 |
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 0.002 | 0.011 | 2.24 | -0.215 |
Total Liabilities & Shareholders' Equity | 0.006 | 0.147 | 2.58 | 0.504 |
Total Common Shares Outstanding |